Related Experiment Video
Updated: Jan 1, 2026

10:25
Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping
Published on: September 25, 2019
49.2K
Identifying Mild Cognitive Impairment with Random Forest by Integrating Multiple MRI Morphological Metrics
Zhe Ma1,2, Bin Jing1,2, Yuxia Li3
1School of Biomedical Engineering, Capital Medical University, Beijing, China.
Journal of Alzheimer'S Disease : JAD
|December 30, 2019
Summary
Early diagnosis of mild cognitive impairment (MCI) is crucial for Alzheimer's disease (AD) prevention. A random forest model combining multiple brain metrics achieved 80% accuracy in identifying MCI, outperforming single metrics.
Area of Science:
- Neuroimaging
- Neurology
- Biomedical Engineering
Background:
- Mild cognitive impairment (MCI) is a precursor to Alzheimer's disease (AD), necessitating early and accurate diagnostic methods.
- Identifying individuals with MCI is critical for timely intervention and potential disease modification.
Purpose of the Study:
- To develop and validate a robust method for early identification of MCI using neuroimaging biomarkers.
- To compare the diagnostic performance of combined morphological metrics against individual metrics.
Main Methods:
- Utilized voxel-based, deformation-based, and surface-based morphometry to extract multiple brain morphological metrics.
- Employed a random forest classifier trained on a discovery dataset (ADNI) and validated on independent datasets.
- Evaluated performance using 10-fold cross-validation and external datasets.
Main Results:
- The combined morphological metrics achieved approximately 80% accuracy in identifying MCI across all datasets.
- This performance significantly surpassed models using single metrics (45%-76% accuracy).
- Cortical thickness and gyrification index emerged as key biomarkers for MCI detection.
Conclusions:
- A multi-metric approach using random forest classification offers a reliable and accurate method for early MCI diagnosis.
- Surface-based morphometry metrics, specifically cortical thickness and gyrification index, are promising biomarkers for MCI.
- This method shows potential for assisting clinicians in the early diagnosis of MCI.

